未登录

T

Tanmay Dichwalkar

koch institute for integrative cancer research at mit

H指数:4

被引数:547

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Enhanced CAR–T cell activity against solid tumors by vaccine boosting through the chimeric receptor

通过嵌合受体增强疫苗增强对实体瘤的car-t细胞活性

IF45.8

2019-01-010

OAAI

Targeting small molecule drugs to T cells with antibody-directed cell-penetrating gold nanoparticles

BIOMATERIALS SCIENCE

IF5.7

2019-01-0169

OAAI

Design, synthesis, selection, and evaluation of a potent multi-kinase targeting N4-phenylsubstituted-7H-pyrrolo[2,3-d]pyrimidin-4-amine derivative with significant anticancer activity in P53 mutant and wild type models of upper gastrointestinal cancers

CANCER RESEARCH

IF16.6

2018-07-010

PRE

Omega-3 Fatty Acid Grafted PAMAM-Paclitaxel Conjugate Exhibits Enhanced Anticancer Activity in Upper Gastrointestinal Cancer Cells

MACROMOLECULAR BIOSCIENCE

IF4.1

2017-05-0927

PREAI

Dichloro [4,40-bis(4,4,4-trifluorobutyl)-2,20-bipyridine] platinum, a novel Cisplatin analog, exhibits enhanced anticancer activity in preclinical models of upper gastrointestinal cancers

CANCER RESEARCH

IF16.6

2016-07-150

PRE

Rigosertib synergistically enhances the anticancer activity of Cisplatin in various preclinical models of upper gastrointestinal cancers

CANCER RESEARCH

IF16.6

2016-07-150

PRE

Omega-3 fatty acid conjugated paclitaxel dendrimers exhibit enhanced anticancer activity in various preclinical models of gastrointestinal cancers

CANCER RESEARCH

IF16.6

2016-07-153

PRE

Potent anticancer activity of an orally bioavailable small molecule, ON 013100, and its water soluble derivative, briciclib, a clinical-stage eIF4E-targeted agent

CANCER RESEARCH

IF16.6

2015-08-010

PRE